Vigorous HIV-1-specific CD4(+) T cell responses associated with control of viremia

被引:1557
作者
Rosenberg, ES
Billingsley, JM
Caliendo, AM
Boswell, SL
Sax, PE
Kalams, SA
Walker, BD
机构
[1] MASSACHUSETTS GEN HOSP, PARTNERS AIDS RES CTR, BOSTON, MA 02114 USA
[2] MASSACHUSETTS GEN HOSP, INFECT DIS UNIT, BOSTON, MA 02114 USA
[3] HARVARD UNIV, SCH MED, BOSTON, MA 02114 USA
[4] MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02114 USA
[5] FENWAY COMMUNITY HLTH CTR, BOSTON, MA 02115 USA
[6] BRIGHAM & WOMENS HOSP, DIV INFECT DIS, BOSTON, MA 02115 USA
关键词
D O I
10.1126/science.278.5342.1447
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Virus-specific CD4(+) T helper lymphocytes are critical to the maintenance of effective immunity in a number of chronic viral infections, but are characteristically undetectable in chronic human immunodeficiency virus-type 1 (HIV-1) infection. In individuals who control viremia in the absence of antiviral therapy, polyclonal, persistent, and vigorous HIV-1-specific CD4(+) T cell proliferative responses were present, resulting in the elaboration of interferon-gamma and antiviral beta chemokines. In persons with chronic infection, HIV-1-specific proliferative responses to p24 were inversely related to viral load. Strong HIV-1-specific proliferative responses were also detected following treatment of acutely infected persons with potent antiviral therapy. The HIV-1-specific helper cells are likely to be important in immunotherapeutic interventions and vaccine development.
引用
收藏
页码:1447 / 1450
页数:4
相关论文
共 42 条
[31]   IN-VITRO LYMPHOCYTE PROLIFERATIVE RESPONSE TO HIV-1 P24 IS ASSOCIATED WITH A LACK OF CD4(+) CELL DECLINE [J].
PONTESILLI, O ;
CARLESIMO, M ;
VARANI, AR ;
FERRARA, R ;
DOFFIZI, G ;
AIUTI, F .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (02) :113-114
[32]   T-CELL FUNCTION IN-VITRO IS AN INDEPENDENT PROGRESSION MARKER FOR AIDS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED ASYMPTOMATIC SUBJECTS [J].
ROOS, MTL ;
MIEDEMA, F ;
KOOT, M ;
TERSMETTE, M ;
SCHAASBERG, WP ;
COUTINHO, RA ;
SCHELLEKENS, PTA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) :531-536
[33]  
ROSENBERG E, UNPUB
[35]  
SCHRIER RD, 1989, J IMMUNOL, V142, P1166
[36]   ABSENCE OF RECOVERABLE INFECTIOUS VIRUS AND UNIQUE IMMUNE-RESPONSES IN AN ASYMPTOMATIC HIV+ LONG-TERM SURVIVOR [J].
SCHWARTZ, D ;
SHARMA, U ;
BUSCH, M ;
WEINHOLD, K ;
MATTHEWS, T ;
LIEBERMAN, J ;
BIRX, D ;
FARZEDAGEN, H ;
MARGOLICK, J ;
QUINN, T ;
DAVIS, B ;
BAGASRA, O ;
POMERANTZ, R ;
VISCIDI, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (12) :1703-1711
[37]   Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1 [J].
Stanley, SK ;
Ostrowski, MA ;
Justement, JS ;
Gantt, K ;
Hedayati, S ;
Mannix, M ;
Roche, K ;
Schwartzentruber, DJ ;
Fox, CH ;
Fauci, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (19) :1222-1230
[38]  
Thomsen AR, 1996, J IMMUNOL, V157, P3074
[39]   CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge [J].
vonHerrath, MG ;
Yokoyama, M ;
Dockter, J ;
Oldstone, MBA ;
Whitton, JL .
JOURNAL OF VIROLOGY, 1996, 70 (02) :1072-1079
[40]   CHARACTERISTICS OF THE SPECIFIC CELL-MEDIATED IMMUNE-RESPONSE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION [J].
WAHREN, B ;
MORFELDTMANSSON, L ;
BIBERFELD, G ;
MOBERG, L ;
SONNERBORG, A ;
LJUNGMAN, P ;
WERNER, A ;
KURTH, R ;
GALLO, R ;
BOLOGNESI, D .
JOURNAL OF VIROLOGY, 1987, 61 (06) :2017-2023